tiprankstipranks
Advertisement
Advertisement

HK:9969 Stock Latest News

InnoCare Pharma Sets April Board Meeting to Approve Q1 2026 Results
Company AnnouncementsInnoCare Pharma Sets April Board Meeting to Approve Q1 2026 Results
3d ago
InnoCare Pharma Moves to Modernize Governance With New Corporate Charter
PremiumCompany Announcements
InnoCare Pharma Moves to Modernize Governance With New Corporate Charter
19d ago
InnoCare Tightens Audit Committee Rules to Bolster Governance
PremiumCompany Announcements
InnoCare Tightens Audit Committee Rules to Bolster Governance
19d ago
InnoCare Pharma Tightens Governance With Formal Compensation Committee Mandate
PremiumCompany Announcements
InnoCare Pharma Tightens Governance With Formal Compensation Committee Mandate
19d ago
InnoCare Pharma Updates Nomination Committee Governance Framework
PremiumCompany Announcements
InnoCare Pharma Updates Nomination Committee Governance Framework
19d ago
InnoCare Pharma Swings to Profit on Surging Drug Sales and Licensing Revenue
PremiumCompany AnnouncementsInnoCare Pharma Swings to Profit on Surging Drug Sales and Licensing Revenue
19d ago
InnoCare Pharma Adjusts Internal Allocation of STAR Market Share Proceeds
Premium
Company Announcements
InnoCare Pharma Adjusts Internal Allocation of STAR Market Share Proceeds
19d ago
InnoCare Pharma Updates Company Secretary and Governance Roles
Premium
Company Announcements
InnoCare Pharma Updates Company Secretary and Governance Roles
19d ago
InnoCare Pharma Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
InnoCare Pharma Sets March 2026 Board Meeting to Approve 2025 Annual Results
1M ago
InnoCare Pharma Forecasts First Annual Profit in 2025 on Surging Drug Sales
PremiumCompany Announcements
InnoCare Pharma Forecasts First Annual Profit in 2025 on Surging Drug Sales
2M ago
InnoCare Pharma Grants 1.4 Million RSUs Under 2023 Share Award Scheme
PremiumCompany Announcements
InnoCare Pharma Grants 1.4 Million RSUs Under 2023 Share Award Scheme
3M ago
InnoCare Pharma achieves primary endpoint in Phase 2b study of orelabrutinib
PremiumThe Fly
InnoCare Pharma achieves primary endpoint in Phase 2b study of orelabrutinib
4M ago
ZBIO
InnoCare Pharma announces phase IIb study of orelabrutinib met primary endpoint
PremiumThe FlyInnoCare Pharma announces phase IIb study of orelabrutinib met primary endpoint
4M ago
InnoCare Pharma Advances Orelabrutinib with Positive SLE Trial Results
Premium
Company Announcements
InnoCare Pharma Advances Orelabrutinib with Positive SLE Trial Results
4M ago
InnoCare Pharma announces NMPA approval for zurletrectinib in China
Premium
The Fly
InnoCare Pharma announces NMPA approval for zurletrectinib in China
4M ago
InnoCare Pharma Gains Approval for Innovative Cancer Treatment in China
PremiumCompany Announcements
InnoCare Pharma Gains Approval for Innovative Cancer Treatment in China
4M ago
InnoCare Pharma Releases Q3 2025 Financials and Updates Nomination Committee
PremiumCompany Announcements
InnoCare Pharma Releases Q3 2025 Financials and Updates Nomination Committee
5M ago
9969
InnoCare Pharma Schedules Board Meeting to Review Q3 Results
PremiumCompany Announcements
InnoCare Pharma Schedules Board Meeting to Review Q3 Results
5M ago
9969
InnoCare Pharma’s Promising Phase I Study on ICP-248 for B-cell Malignancies
PremiumCompany Announcements
InnoCare Pharma’s Promising Phase I Study on ICP-248 for B-cell Malignancies
6M ago
9969
InnoCare Pharma’s Phase 3 Study on Orelabrutinib for Mantle Cell Lymphoma: A Market Game Changer?
PremiumCompany AnnouncementsInnoCare Pharma’s Phase 3 Study on Orelabrutinib for Mantle Cell Lymphoma: A Market Game Changer?
6M ago
9969
InnoCare Pharma Announces Strategic Collaboration with Zenas BioPharma
Premium
Company Announcements
InnoCare Pharma Announces Strategic Collaboration with Zenas BioPharma
6M ago
9969
InnoCare Pharma Announces Grant of Restricted Shares Under 2024 Incentive Scheme
Premium
Company Announcements
InnoCare Pharma Announces Grant of Restricted Shares Under 2024 Incentive Scheme
8M ago
9969

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >